Pfizer Inc.
PFE
$43.56
-$0.1983-0.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Weiss Ratings | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B+ | |||
Rating Factors | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Excellent | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.50 | |||
Price History | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.50% | |||
30-Day Total Return | -14.85% | |||
60-Day Total Return | -5.89% | |||
90-Day Total Return | -0.19% | |||
Year to Date Total Return | -14.22% | |||
1-Year Total Return | -15.32% | |||
2-Year Total Return | 34.03% | |||
3-Year Total Return | 34.84% | |||
5-Year Total Return | 57.71% | |||
52-Week High % Change | -22.30% | |||
52-Week Low % Change | 5.59% | |||
Price | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $56.32 | |||
52-Week Low Price | $41.45 | |||
52-Week Low Price (Date) | Oct 11, 2022 | |||
52-Week High Price (Date) | Apr 11, 2022 | |||
Valuation | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $245.64B | |||
Enterprise Value | 246.76B | |||
Price/Earnings (TTM) | 8.41 | |||
Earnings Per Share (TTM) | 5.21 | |||
Earnings Per Share Growth | 52.28% | |||
Price/Earnings To Growth | 0.16 | |||
Price/Sales (TTM) | 2.51 | |||
Price/Book (Q) | 2.65 | |||
Enterprise Value/Revenue (TTM) | 2.48 | |||
Price | $43.57 | |||
Enterprise Value/EBITDA (TTM) | 5.50 | |||
Enterprise Value/EBIT | 6.16 | |||
Market Cap Category | Mega Cap | |||
Dividends and Shares | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 5.718B | |||
Dividend Yield | 3.68% | |||
Div. Per Share (Most Recent) | $0.41 | |||
Dividend Per Share (TTM) | $1.61 | |||
Payout Ratio (TTM) | 22.45% | |||
Dividend Per Share (Most Recent) | $0.41 | |||
Company Info | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 212 733 2323 | |||
Address | 235 East 42nd Street New York, NY 10017 | |||
Website | www.pfizer.com | |||
Country | United States | |||
Year Founded | 1849 | |||
Profitability | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 40.19% | |||
Profit Margin | 29.86% | |||
Management Effectiveness | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 13.37% | |||
Return on Equity | 35.83% | |||
Income Statement | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $99.68B | |||
Total Revenue (TTM) | $99.68B | |||
Revenue Per Share | $17.43 | |||
Gross Profit (TTM) | $65.95B | |||
EBITDA (TTM) | $44.87B | |||
EBIT (TTM) | $40.07B | |||
Net Income (TTM) | $29.77B | |||
Net Income Avl. to Common (TTM) | $29.77B | |||
Total Revenue Growth (Q YOY) | -5.81% | |||
Earnings Growth (Q YOY) | 5.79% | |||
EPS Diluted (TTM) | $5.21 | |||
EPS Diluted Growth (Q YOY) | 5.51% | |||
Balance Sheet | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $36.13B | |||
Cash Per Share (Q) | $6.32 | |||
Total Current Assets (Q) | $70.40B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $92.89B | |||
Current Ratio (Q) | 1.589 | |||
Book Value Per Share (Q) | $16.51 | |||
Total Assets (Q) | $195.35B | |||
Total Current Liabilities (Q) | $44.31B | |||
Total Debt (Q) | $37.00B | |||
Total Liabilities (Q) | $102.46B | |||
Total Common Equity (Q) | $92.63B | |||
Cash Flow | PFE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$2.65B | |||
Cash from Financing (TTM) | -$15.69B | |||
Net Change in Cash (TTM) | -$8.00M | |||
Levered Free Cash Flow (TTM) | $15.11B | |||
Cash from Operations (TTM) | $18.43B | |||